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Abstract
Background: DAPfinder and DAPview are novel BRB-ArrayTools plug-ins to construct gene coexpression networks
and identify significant differences in pairwise gene-gene coexpression between two phenotypes.
Results: Each significant difference in gene-gene association represents a Differentially Associated Pair (DAP). Our
tools include several choices of filtering methods, gene-gene association metrics, statistical testing methods and
multiple comparison adjustments. Network results are easily displayed in Cytoscape. Analyses of glioma
experiments and microarray simulations demonstrate the utility of these tools.
Conclusions: DAPfinder is a new friendly-user tool for reconstruction and comparison of biological networks.
Background
Microarray researchers need easy-to-use tools to identify
differences in the coexpression and coregulation of genes
between phenotypes that cannot be identified with tradi-
tional tools. Often researchers compute Student’st - t e s t s ,
analysis of variance (ANOVA), significance analysis of
microarrays [1] or empirical Bayes analysis [2] for each
gene on their microarray to identify individual differen-
tially expressed genes (DEGs) among two or more phe-
notypes [3]. Unfortunately, these approaches ignore
coexpression because they cannot account for the com-
plex multivariate relationships among genes. Multivariate
statistical methods like hierarchical clustering and princi-
ple components analysis (PCA) are often used for quality
control and exploration of microarray data. However,
these multivariate methods do not effectively model
coexpression nor do they allow for hypothesis tests to
compare phenotypes. Gene-gene association networks
built using ARACNe [4], context likelihood relatedness
(CLR) [5], maximum relevancy (MR) [6,7] and other
methods often provide helpful models of coexpression
and coregulation, but the networks are based on data
f r o mas i n g l ep h e n o t y p ea n da r en o te a s i l yc o m p a r e d
using statistical tests. New methods are needed to
account for the complex relationships among genes while
providing hypothesis tests to compare phenotypes.
Several research groups have addressed the question of
comparing the coexpression of specific gene-gene pairs
or coexpression networks among two or more pheno-
types. Two early examples used search algorithms to
identify optimally sized clusters of coexpressed genes and
resampling tests to identify significant differences among
the coexpressed clusters between phenotypes [8,9]. Other
published methods used variations on familiar statistical
techniques like Fisher’s Z tests or modified F-statistics to
directly compare pairwise gene-gene correlations
between two phenotypes [10-12]. Some of these meth-
ods [10,11,13] are readily available as source scripts of
package libraries in R http://www.r-project.org. Some
interesting approaches apply the results from statistical
tests that compare pairwise gene-gene associations
between two phenotypes to the construction and inter-
pretation of gene coexpression networks [10,14]. Both of
these methods allow researchers to explore the complex
differences among gene expression networks using statis-
tical tests, but unfortunately neither method has been
implemented in a user-friendly tool.
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any medium, provided the original work is properly cited.DAPfinder and DAPview are plug-ins for BRB-Array-
Tools http://linus.nci.nih.gov/BRB-ArrayTools.html, which
will provide researchers with accessible tools to test differ-
ences in the coexpression between two phenotypes and
explore those results on gene association networks. BRB-
ArrayTools is a comprehensive microarray analysis pack-
age that does not require specific skills in programming or
direct script usage. It is available for free to non-commer-
cial users and has more than 11,000 users in 65 coun-
tries [15]. Our DAPfinder and DAPview tools will identify
and visualize individual significant differences in gene-
gene association between the two classes, each of which
we will call a Differentially Associated Pair (DAP). Output
from these tools can be used to construct gene-gene asso-
ciation networks and identify the significant differences in
coexpression between two groups. Our hope is that these
tools can be used to identify systems-level features in the
gene-gene association networks like network growth or
decay, network merging or splitting, and network birth or
death, reflecting functional changes in biological pathways.
Implementation
DAPfinder
DAPfinder is used to compute pair-wise gene-gene asso-
ciations (i.e. gene-gene correlations) for two groups of
microarray experiments, then compare each specific gene-
gene association between the two groups with a statistical
test (Additional file 1, Figure S1). Gene-gene associations
can be estimated using Pearson correlation coefficients,
Spearman rank correlation coefficients, Kendall rank cor-
relation coefficients or mutual information. Pearson corre-
lations are the most familiar metric and the easiest to
compute, but only the Spearman, Kendall and mutual
information metrics are appropriate for nonlinear associa-
tions between genes. Significant Pearson correlations
within each class are identified using a one-sample Fisher’s
Z-test. Differences in gene-gene correlations (i.e. Pearson,
Spearman and Kendall) are automatically tested using
Fisher’s Z-test methods, while optional permutation tests
are used to compare differences in gene-gene correlation
or mutual information. P-values from the Fisher’s Z-test
methods are approximate p-values that assume large sam-
ple sizes; permutation tests make no assumption about
sample size, but they require lengthy computation times.
Permutation test calculations can be hastened by choosing
from one of four gene-gene pair subset selection methods
(Additional file 1, Figure S1). Tests can be computed with
equal numbers of permutations for each gene-gene pair or
with an adaptive method that identifies the minimum
number of permutations required for each gene-gene pair.
Fisher’s Z-tests of individual Pearson correlations within
each class or differences in correlation between the
two classes can be corrected for multiple testing using
false discovery rate (FDR) methods [16,17], q-value
methods [18-20] or Bonferroni family-wise error rate
(FWER) methods using step-up adjusted p-values [21].
The same multiple testing adjustments can be applied to
the optional permutation tests. Researchers can pre-filter
individual genes by the coefficient of variation (CV) of
their gene expression, by a minimum sample size criteria
(after outliers and missing data have been removed) or
using the internal methods of BRB-ArrayTools. Research-
ers can also upload a specific list of gene-gene pairs for
testing. Outliers among the individual expression values
from each gene can be removed using univariate standard
deviation or interquartile range (IQR) criteria.
Output from DAPfinder includes a hyper-text markup
language (HTML) report and comprehensive output
stored as an Excel spreadsheet or tab-delimited text file.
The HTML report opens up automatically in a web
browser to display the current user settings and diagnos-
tics from the analyses. Reported user settings include
choices of pre-filtering methods, association metrics and
statistical tests, plus the directory location of the results.
Diagnostics include the amount of missing data, the
number of genes and gene-gene pairs used in the calcula-
tions and the computation time required. Optionally, the
10 most significant results from the Fisher’s Z-tests and
permutation test can be added to the HTML report. The
comprehensive output includes the unique IDs and
related annotations for both genes in each gene-gene
pair, the individual gene-gene associations for each of the
two groups with test statistics and p-values reported for
the Pearson correlations in each group, the Fisher’s
Z-test statistics and p-values for comparisons between
the two groups and finally the differences in association
and permutation p-values between the two groups (if
requested). These results can be sorted and reorganized
in Excel to identify the most significant gene-gene asso-
ciations in a single group, the most significant Fisher’s
Z-test results, etc. Results from the comprehensive
output file can be directly imported into visualization
software packages like Cytoscape [[22], http://www.cytos-
cape.org] to create network graphs using the two col-
umns of unique IDs to define nodes and the columns of
correlation coefficients or p-values to define edge
weights. Both the HTML report and the comprehensive
output are automatically saved to the user’sB R B - A r r a y -
Tools project folder.
DAPview
DAPview graphs the expression values for two specific
genes in a XY scatter plot with the differences in coex-
pression between two phenotypes displayed in different
colors and symbols (Figure 1). Typically, a statistically
significant difference in gene-gene association would be
discovered using DAPfinder, then the relationship can
be visualized with DAPview. The two groups are
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legend clearly identifying each group. Researchers can
choose to identify, eliminate or ignore the outlier
expression values identified by the same univariate stan-
dard deviation or interquartile (IQR) range criteria from
DAPfinder. Identified outliers are plotted in red, while
eliminated outliers are completely removed from the
graph and ignored outliers are plotted in the same col-
ors as the legitimate data. Scatter plot graphs are auto-
matically opened in portable document file (PDF)
format and saved into the user’s BRB-ArrayTools project
folder.
Results
Evaluation of DAPfinder with Simulated Microarray Data
The efficacy of the DAPfinder procedures was evaluated
using simulated microarray data with known gene-gene
correlations to ensure its statistical methods can detect
known differences in gene-gene association with high
levels of statistical power and low levels of false posi-
tives. See the supplementary materials (Additional file 1)
for details on the generation of simulated microarray
data and other simulation methods. Simulation results
were used to create receiver-operator characteristic
(ROC) curves that explore the relationships between sta-
tistical power, sample size and effect strength under sev-
eral different simulation conditions. Other simulations
examined the relationship between approximate p-values
from the Fisher’s Z-tests and exact p-values from the
permutation tests. Simulations were conducted entirely
in R using the same R source code used to build
DAPfinder.
Examining changes in Area Under Curve (AUC) for the
ROC quickly revealed many properties of the analyses in
DAPfinder. Not surprisingly, results from the simulations
show that sensitivity (i.e. statistical power) and specificity
(i.e. control over false positives) increase as sample sizes
(n) or differences in correlation (delta = Δr = ri - rj)
increase (Figure 2) when all other experimental condi-
tions are held constant (Additional file 1, supplementary
information). These results show the DAPfinder per-
forms well even for relatively small sample sizes and dif-
ferences in correlation. Increasing as the number of
genes on each microarray chip did not affect sensitivity
or specificity (Additional file 1, Figure S6), supporting
our decision to use simulations with a small number of
genes per chip because they are more efficient (see Addi-
tional file 1, supplementary materials, for details). In the
real world, increasing the number of genes per chip
would decrease statistical power due to the more conser-
vative FDR- and FWER adjustments for multiple testing
and possible due to higher level interactions among large
numbers of genes. However, these simulations computed
ROC curves using unadjusted p-values and fixed num-
bers of interacting genes. It may be surprising that sensi-
tivity and specificity did not change as the expression
variances of individual genes increased (Additional file 1,
Figure S7) with all other experimental conditions held
constant. However, increasing the individual gene expres-
sion variance does not affect sensitivity and specificity,
because the correlation of two genes is a property of the
joint distribution that is not solely dependent on the
magnitude of individual gene expression variances. Per-
haps the most important simulation result showed that
sensitivity and specificity increased as correlation coeffi-
cients from the two groups changes from perfectly sym-
metric with ri - rj = +0.5 - (-0.5) = 1 to increasingly
asymmetric coefficients like ri - rj = +0.95 - (-0.05) = 1 or
ri - rj = +0.05 - (-0.95) = 1 with all other conditions held
constant (Figure 3). Asymmetric correlation coefficients
have more statistical power because the nonlinear Fish-
er’s Z-transformation used in the Fisher’sZ - t e s ti n f l a t e s
z-scores for strong correlations and deflates z-scores for
moderate correlations (Additional file 1, Figure S8),
creating larger differences in Z-scores and more signifi-
cant Fisher’s Z-tests.
Additional simulations showed approximate p-values
from the Fisher’s Z-test of differences in Pearson corre-
lation are strongly correlated to the exact p-values from
the permutation tests, and the correlation between the
approximate and exact p-values increases with sample
size (Additional file 1, Figure S9). Similar correlations
between approximate p-values and exact p-values are
seen for differences in Spearman rank correlation and
Figure 1 Negative correlation between MYTL1 gene (probe set
216672_at) and SOX5 gene (probe set 207336_at) in
oligodendrogliomas (ODG) and no association between SOX5
and MYTL1 in glioblastoma multiforme (GBM) illustrated using
the DAPview.
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These show the robust results from computationally
intensive permutation and resampling tests can be very
closely approximated by much faster Fisher’sZ - t e s ta n d
similar methods for Spearman and Kendall rank
correlations with reasonable sample sizes. Both options
are included to provide researchers the option of faster
computation when sample sizes are relatively large or
more robust results when sample sizes are smaller.
Discoveries from Glioma Data
To illustrate some possible uses of the DAPfinder, we ana-
lyzed transcriptional data from glioma samples publicly
available in the Repository of Molecular Brain Neoplasia
Data (REMBRANDT) [[23], http://caintegrator.nci.nih.
gov/rembrandt]. We used data from oligodendroglioma
(ODG) and glioblastoma multiforme (GBM) samples
representing low and high malignancy primary adult brain
tumors, respectively [24]. We identified significant differ-
ences in Pearson correlation (p < 0.10 and ri - rj >0 . 5 0 )
between ODG and GBM tumors for 727 gene-gene pairs
which were consistent in tumors from two independent
studies at Henry Ford Hospital [25] and the Glioma Mole-
cular Diagnostics Initiative (GMDI) [26]. We constructed
a gene-gene association network by focusing on a cluster
of 27 gene-gene pairs (from 20 genes) with significant dif-
ferences in Pearson correlation between ODG and GBM
tumors and an additional 85 gene-gene pairs (from 56
genes) that are connected to this cluster of 27 DAPs by
correlations of similar strength and direction in both
classes of gliomas (Figure 5). See supporting materials for
details.
We noticed three features in the network that were not
necessarily expected. First, more than half of the genes
Figure 2 Effects of sample size and and difference in correlation. Left. Effect of increasing sample size on ROC AUC with 40 genes per chip,
250 simulation runs and constant delta = Δr = ri - rj = +0.5 - (-0.5) = 1. Right. Effect of increasing difference in correlation between classes from
delta = ri - rj = +0.55 - (-0.55) = 1.1 to ri - rj = +0.95 - (-0.95) = 1.9 on ROC AUC with 40 genes per chip, 250 simulation runs and constant
sample size n = 5 chips per class.
Figure 3 Effect of increasing asymmetry on ROC AUC.
Asymmetry was increased from ri - rj = +0.5 - (-0.5) = 1) to ri - rj =
+0.95 - (-0.05) = 1 with 40 genes per chip, 250 simulation runs and
constant sample size n = 10 chips per class.
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the two classes of glioma (46 out 76 genes). This suggests
there may be a general correlation between differential
expression and differences in association between pheno-
types. Second, the relationship between differential
expression and direction of correlation from consistent
edges may represent potential regulatory relationships
among genes. Positive correlations occur whenever both
genes are up- or down-regulated, while negative correla-
tions occur whenever one gene is up-regulated and the
other is down-regulated. Note, because the correlations
are estimated within the same type of samples, either
ODG or GBM, the fact that genes are up- or down-regu-
lated in GBM relative to ODG should not influence the
correlation results. This phenomenon is seen in all 48
correlations that are consistent between the ODG and
GBM tumors. Third, the significant differences in gene-
gene association seem to reflect the biological differences
between ODG and GBM. Correlations that change direc-
tion between glioma types typically show strong positive
or negative correlations consistent with regulation in
ODG, while having zero correlation in GBM. This sug-
gests that evolution of the tumor may lead to the loss of
regulatory relationships in the de-differentiating tissue.
The gene-gene association shrinks from 76 genes and
110 gene-gene pairs in ODG to 69 genes and 87 gene-
gene pairs in GBM, suggesting systems-level network
shrinkage from ODG to GBM resulting in loss of regula-
tion functions.
Among the significant correlation changes in the net-
work, we find three genes (MYT1L, EGFR, POSTN) known
to have meaningful roles in glioma pathogenesis [27-29].
Myelin transcription factor 1 (MYTL1) is upregulated in
the less malignant ODG tumors and it is a major factor
necessary for neuronal differentiation [30]. The significant
difference in Pearson correlation between SOX5 and
MYTL1 in ODG and GBM tumors is visualized with DAP-
view (Figure 1). Epidermal growth factor receptor (EGFR)
is a famous member of the erbB family of receptors that
involved in regulation of cell proliferation and differentia-
tion. Deregulation of EGFR was shown to have critical role
in gliomas [31] as well as in several other malignan-
cies [32-36]. Up-regulationi nt h ep r o t e i n - c o d i n gg e n e
POSTN (periostin) is correlated with metastasis in both
melanoma and breast cancer [37]. Although this analysis
does not allow for definitive biological conclusions, it finds
both previously established genes essential for tumorgenesis
as wells as points to a new previously unexplored area of
transcriptional regulation of gliomas. These results support
t h ei d e at h a te s t i m a t i n gn o to n l yt h es t r u c t u r eb u ta l s o
changes in the co-expression gene networks can be a useful
approach for understanding the disease process.
Conclusions
Analyses of empirical and simulated microarray data have
shown that DAPfinder is a powerful tool to reconstruct
and compare gene regulatory networks. Its design is not
restricted to gene expression data from single channel
and dual channel microarray experiments. The tool can
also be used with expression data from RNA-Seq reads
or it can analyze complex quantitative biological data like
comparative genomic hybridization (CGH), metabolome,
microbiome and proteome data. DAPfinder can also be
used to compute gene-gene associations and construct
Figure 4 Effect of increasing sample size on the relationship between analytical (i.e. approximate) p-values from Fisher’sZ - t e s t
procedures and permutation (i.e. exact) p-values.
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second phenotype for comparisons of gene-gene associa-
tions and networks. DAPfinder can be used within BRB-
ArrayTools by biologists without specific skills in
programming and/or direct script usage. Indeed, we have
recently employed the tool in the meta-analysis of cervi-
cal cancer gene expression and comparative genomic
hybridization data revealing critical events of tumor pro-
gression (Mine KL, Shulzhenko N, Yambartsev A, et al.:
Reconstruction of an integrative gene regulatory meta-
network reveals cell cycle and antiviral response as major
drivers of cervical cancer, submitted). Future versions
may extend the utility of the statistical tests and graphs
to problems with 3 or more phenotypes, while alternative
gene-gene association metrics and statistical tests can
also be explored to ensure proper networks construction.
Availability and requirements
DAPfinder and DAPview may be downloaded for free
from the NIAID Exon website http://exon.niaid.nih.gov/
Figure 5 A gene-gene association network created in Cytoscape using output from DAPfinder. Nodes with yellow fill identify genes
involved in statistically significant DAPs. Nodes with gray fill identify genes that were not involved in any significant differences in gene-gene
correlation between ODG and GBM tumors, but consistently correlate with the “yellow” genes in both ODG and GBM. Nodes with red borders
indicate that a gene was upregulated in ODG, nodes with green borders represent genes that were downregulated in ODG and nodes with no
border did not have any significant differential expression. Orange edges represent positive correlations between two genes in the ODG tumors.
Blue edges denote negative correlations between genes in ODG tumors. Gray edges represent strong correlations in the GBM tumors, but no
correlation in ODG tumors. Solid edges represent correlations that are consistent in both ODG and GBM tumors, while dashed edges represent
statistically significant DAPs where correlations are not consistent among ODG and GBM groups.
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Page 6 of 8dapfinder/index.html. Complete installation instructions
are provided on the website. DAPfinder and DAPview
requires the installation of BRB-ArrayTools. BRB-Array-
Tools currently requires the installation of Microsoft
Excel, Java Virtual Machine, R 2.12.0 or higher and stat-
connDCOM on computer using the Microsoft Windows
operating system. DAPfinder and DAPview are BRB-
ArrayTools plug-ins, which mostly utilize open source R
script files. A complete description of the DAPfinder
and DAPview files can be found in our supplementary
materials (Additional file 1). DAPfinder and DAPview
are also available to download as Additional Files 2
and 3.
Additional material
Additional file 1: Additional information and Supplemental figures
not included in the article. Additional Details About DAPfinder
Methods; Development details of DAPfinder and DAPview; Validation of
DAPfinder with Simulated Microarray Data; Discoveries from Glioma Data.
Additional file 2: DAPfinder. DAPfinder plug-in software for BRB-
ArrayTools.
Additional file 3: DAPview. DAPview plug-in software for BRB-
ArrayTools.
List of abbreviations
ANOVA: Analysis of Variance; ARACNe: Algorithm for the Reconstruction of
Accurate Cellular Networks; AUC: Area Under Curve; CGH: Comparative
Genomic Hybridization; CLR: Context Likelihood of Relatedness; CV:
Coefficient of Variation; DAP: Differentially Associated Pair; DEG: Differentially
Expressed Gene; FDR: False Discovery Rate; FWER: Family-Wise Error Rate;
GBM: Glioblastoma multiforme; GMDI: Glioma Molecular Diagnostics
Initiative; HTML: Hyper Text Markup Language; IQR: Interquartile Range; MR:
Maximum Relatedness or Minimum Redundancy; ODG: Oligodendroglioma;
PCA: Principle Components Analysis; PDF: Portable Document File;
REMBRANDT: Repository of Molecular Brain Neoplasia Data; ROC: Receiver
Operator Characteristic.
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